Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome

Journal of Clinical Oncology

Volumn 29, Issue 11, 2011, Pages 1424-1430

  Cho, Yoon Jae ^{a,b,c,d,e,f,g,h,i,j,k}   Tsherniak, Aviad ^{a,b,c,d,e,f,g,h,i,j,k}   Tamayo, Pablo ^{a,b,c,d,e,f,g,h,i,j,k}   Santagata, Sandro ^{a,b,c,d,e,f,g,h,i,j,k}   Ligon, Azra ^{a,b,c,d,e,f,g,h,i,j,k}   Greulich, Heidi ^{a,b,c,d,e,f,g,h,i,j,k}   Berhoukim, Rameen ^{a,b,c,d,e,f,g,h,i,j,k}   Amani, Vladimir ^{a,b,c,d,e,f,g,h,i,j,k}   Goumnerova, Liliana ^{a,b,c,d,e,f,g,h,i,j,k}   Eberhart, Charles G ^{a,b,c,d,e,f,g,h,i,j,k}   Lau, Ching C ^{a,b,c,d,e,f,g,h,i,j,k}   Olson, James M ^{a,b,c,d,e,f,g,h,i,j,k}   Gilbertson, Richard J ^{a,b,c,d,e,f,g,h,i,j,k}   Gajjar, Amar ^{a,b,c,d,e,f,g,h,i,j,k}   Delattre, Olivier ^{a,b,c,d,e,f,g,h,i,j,k}   Kool, Marcel ^{a,b,c,d,e,f,g,h,i,j,k}   Ligon, Keith ^{a,b,c,d,e,f,g,h,i,j,k}   Meyerson, Matthew ^{a,b,c,d,e,f,g,h,i,j,k}   Mesirov, Jill P ^{a,b,c,d,e,f,g,h,i,j,k}   Pomeroy, Scott L ^{a,b,c,d,e,f,g,h,i,j,k}  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^j INSTITUT CURIE   (France)

^k ACADEMIC MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTOME;

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CANCER SURVIVAL; CHILD; DISEASE COURSE; EVENT FREE SURVIVAL; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENOMICS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79954991010     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.28.5148     Document Type: Article

References (36)

1. Pomeroy SL, Tamayo P, Gaasenbeek M, et al: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442, 2002 (Pubitemid 34100955)
2. Brunet JP, Tamayo P, Golub TR, et al: Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci U S A 101:4164-4169, 2004 (Pubitemid 38405900)
3. Kool M, Koster J, Bunt J, et al: Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3:e3088, 2008
4. Thompson MC, Fuller C, Hogg TL, et al: Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24:1924-1931, 2006 (Pubitemid 46638992)
5. Kim JY, Nelson AL, Algon SA, et al: Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice. Dev Biol 263:50-66, 2003 (Pubitemid 37268003)
6. Clifford SC, Lusher ME, Lindsey JC, et al: Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Cell Cycle 5:2666-2670, 2006
7. Fattet S, Haberler C, Legoix P, et al: Betacatenin status in paediatric medulloblastomas: Correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics. J Pathol 218:86-94, 2009
8. Lo KC, Rossi MR, Eberhart CG, et al: Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization. Brain Pathol 17:282-296, 2007 (Pubitemid 47000637)
9. Lo KC, Rossi MR, Burkhardt T, et al: Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas. Genes Chromosomes Cancer 46:53-66, 2007 (Pubitemid 44772872)
10. Northcott PA, Nakahara Y, Wu X, et al: Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 41:465-472, 2009
11. Ferretti E, De Smaele E, Po A, et al: MicroRNA profiling in human medulloblastoma. Int J Cancer 124:568-577, 2009
12. Ferretti E, De Smaele E, Miele E, et al: Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. Embo J 27:2616-2627, 2008
13. Uziel T, Karginov FV, Xie S, et al: The miR- 17̃92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci U S A 106:2812-2817, 2009
14. Northcott PA, Fernandez-L A, Hagan JP, et al: The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 69:3249-3255, 2009
15. Tamayo P, Cho Y-J, Tsherniak A, et al: Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features. J Clin Oncol (in press)
16. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435:834-838, 2005 (Pubitemid 40839735)
17. Lu Y, Ryan SL, Elliott DJ, et al: Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma. PLoS One 4:e6159, 2009
18. Rousseeuw PJ: Silhouettes: A graphical aid to the interpretation and validation of cluster analysis J Comput Appl Math 20:12, 1987
19. Verhaak RG, Hoadley KA, Purdom E, et al: Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98-110
20. Subramanian A, Tamayo P, Mootha VK, et al: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545-15550, 2005 (Pubitemid 41528093)
21. Barbie DA, Tamayo P, Boehm JS, et al: Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108-112, 2009
22. Beroukhim R, Getz G, Nghiemphu L, et al: Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc Natl Acad Sci U S A 104:20007-20012, 2007
23. Beroukhim R, Mermel CH, Porter D, et al: The landscape of somatic copy number alterations across multiple human cancers. Nature 463:899- 905, 2010
24. Tamayo P, Scanfeld D, Ebert BL, et al: Metagene projection for cross-platform, cross-species characterization of global transcriptional states. Proc Natl Acad Sci U S A 104:5959-5964, 2007 (Pubitemid 47175641)
25. Santagata S, Maire CL, Idbaih A, et al: CRX is a diagnostic marker of retinal and pineal lineage tumors. PLoS One 4:e7932, 2009
26. Firestein R, Bass AJ, Kim SY, et al: CDK8 is a colorectal cancer oncogene that regulates betacatenin activity. Nature 455:547-551, 2008
27. Boon K, Eberhart CG, Riggins GJ: Genomic amplification of orthodenticle homologue 2 in medulloblastomas. Cancer Res 65:703-707, 2005 (Pubitemid 40216425)
28. Ellison DW, Onilude OE, Lindsey JC, et al: Beta-catenin status predicts a favorable outcome in childhood medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol 23:7951-7957, 2005 (Pubitemid 46657395)
29. Chan JA, Krichevsky AM, Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033, 2005 (Pubitemid 40994386)
30. Central Brain Tumor Registry of the United States: Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2005. Central Brain Tumor Registry of the United States, Hinsdale, IL, 2009
31. Louis DN, Ohgaki H, Wiestler OD, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109, 2007 (Pubitemid 47103521)
32. Loscher CJ, Hokamp K, Kenna PF, et al: Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa. Genome Biol 8:R248, 2007
33. Loscher CJ, Hokamp K, Wilson JH, et al: A common microRNA signature in mouse models of retinal degeneration. Exp Eye Res 87:529-534, 2008
34. Viswanathan SR, Mermel CH, Lu J, et al: MicroRNA expression during trophectoderm specification. PLoS One 4:e6143, 2009
35. Romer JT, Kimura H, Magdaleno S, et al: Suppression of the SHH pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 6:229-240, 2004 (Pubitemid 39222036)
36. Sasai K, Romer JT, Lee Y, et al: SHH pathway activity is down-regulated in cultured medulloblastoma cells: Implications for preclinical studies. Cancer Res 66:4215-4222, 2006